← Back to Search

Behavioural Intervention

mHealth Messaging for Tobacco Cessation in People Living With HIV (M2Q2-HIV Trial)

N/A

Waitlist Available

Led By Rajani S Sadasivam, PhD

Research Sponsored by University of Massachusetts, Worcester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-months post-randomization

Awards & highlights

M2Q2-HIV Trial Summary

This trial seeks to reduce the serious public health threat posed by smoking and HIV/AIDS in Vietnam. It will promote use of a government-funded quitline and NRT to help smokers quit.

Who is the study for?

This trial is for adults in Vietnam living with HIV who currently smoke and can read texts. They must not be pregnant, planning pregnancy soon, or have serious mental health issues. Family members of participants or those involved in creating the study's texts are excluded.Check my eligibility

What is being tested?

The study tests a computer-tailored texting intervention aimed at encouraging people with HIV to use Vietnam's Quitline and Nicotine Replacement Therapy to help them stop smoking.See study design

What are the potential side effects?

Since this trial involves motivational text messaging rather than medication, there are no direct medical side effects. However, quitting smoking can lead to withdrawal symptoms like cravings, irritability, and increased appetite.

M2Q2-HIV Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-months post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-months post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Smoking Cessation Rate

Secondary outcome measures

HIV-Related Stigma

NRT Use

Quitline Use

+1 more

M2Q2-HIV Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

The M2Q2-HIV intervention includes 3 functions: 1) Extended CHW services, 2) M2Q2 computer-tailored peer messaging, and 3) texting facilitation to quitline use and the quitline intervention. Our goals are to promote the use of an underused, available, government-funded resource for public health (quitline) and NRT that the quitline provides, thus promoting smoking cessation among PLWH.

Group II: ComparisonActive Control1 Intervention

Comparison smokers will receive five brief "risk of smoking" texts as minimal texting intervention, to enhance blinding to knowledge of randomization group.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Institute of Population, Health and Development, VietnamOTHER

3 Previous Clinical Trials

991 Total Patients Enrolled

University of Massachusetts, WorcesterLead Sponsor

342 Previous Clinical Trials

976,010 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,067 Total Patients Enrolled

Media Library

M2Q2-HIV (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05863923 — N/A

Tobacco Cessation Research Study Groups: Intervention, Comparison

Tobacco Cessation Clinical Trial 2023: M2Q2-HIV Highlights & Side Effects. Trial Name: NCT05863923 — N/A

M2Q2-HIV (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05863923 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research project still available?

"Per the information posted to clinicaltrials.gov, this trial has ceased recruitment; initially listed on April 17th 2023 and last modified on May 8th 2023. Despite no longer recruiting participants, 13 alternate trials remain open for enrollment currently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam

Rajani Sadasivam 2023. "Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05863923.